📣 VC round data is live. Check it out!

Intuitive Surgical Valuation Multiples

Discover revenue and EBITDA valuation multiples for Intuitive Surgical and similar public comparables like Abbott, Thermo Fisher Scientific, Stryker, Danaher and more.

Intuitive Surgical Overview

About Intuitive Surgical

Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.


Founded

1995

HQ

United States

Employees

17.0K

Financials (LTM)

Revenue: $11B
EBITDA: $5B

EV

$151B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Intuitive Surgical Financials

Intuitive Surgical reported last 12-month revenue of $11B and EBITDA of $5B.

In the same LTM period, Intuitive Surgical generated $7B in gross profit, $5B in EBITDA, and $3B in net income.

Revenue (LTM)


Intuitive Surgical P&L

In the most recent fiscal year, Intuitive Surgical reported revenue of $10B and EBITDA of $4B.

Intuitive Surgical is profitable as of last fiscal year, with gross margin of 66%, EBITDA margin of 43%, and net margin of 32%.

See analyst estimates for Intuitive Surgical
LTMLast FY202320242025202620272028
Revenue$11B$10B$7B$8B$10B
Gross Profit$7B$7B$5B$6B$7B
Gross Margin67%66%66%67%66%
EBITDA$5B$4B$2B$3B$4B
EBITDA Margin44%43%31%34%36%
EBIT Margin38%37%25%28%29%
Net Profit$3B$3B$2B$2B$3B
Net Margin32%32%25%28%28%

Financial data powered by Morningstar, Inc.

Intuitive Surgical Stock Performance

Intuitive Surgical has current market cap of $156B, and enterprise value of $151B.

Market Cap Evolution


Intuitive Surgical's stock price is $439.92.

Intuitive Surgical share price decreased by 3.9% in the last 30 days, and by 20.4% in the last year.

Intuitive Surgical has an EPS (earnings per share) of $9.15.

See more trading valuation data for Intuitive Surgical
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$151B$156B4.5%-3.9%-12.6%-20.4%$9.15

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Intuitive Surgical Valuation Multiples

Intuitive Surgical trades at 14.2x EV/Revenue multiple, and 32.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Intuitive Surgical

EV / Revenue (LTM)


Intuitive Surgical Financial Valuation Multiples

As of May 19, 2026, Intuitive Surgical has market cap of $156B and EV of $151B.

Intuitive Surgical has a P/E ratio of 45.4x.

LTMLast FY202320242025202620272028
EV/Revenue14.2x15.0x21.2x18.1x15.0x
EV/EBITDA32.2x34.7x69.1x53.8x41.8x
EV/EBIT37.3x40.2x85.6x64.4x51.4x
EV/Gross Profit21.0x22.8x32.0x26.9x22.8x
P/E45.4x48.1x86.7x67.1x54.6x
EV/FCF44.0x49.7x201.8x116.0x60.7x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Intuitive Surgical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Intuitive Surgical Margins & Growth Rates

Intuitive Surgical grew revenue by 16% and EBITDA by 21% in the last fiscal year.

In the most recent fiscal year, Intuitive Surgical reported gross margin of 66%, EBITDA margin of 43%, and net margin of 32%.

See estimated margins and future growth rates for Intuitive Surgical

Intuitive Surgical Margins

Last FY202420252026202720282029
Gross Margin66%67%66%68%
EBITDA Margin43%34%36%45%
EBIT Margin37%28%29%39%
Net Margin32%28%28%32%
FCF Margin30%16%25%35%

Intuitive Surgical Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth16%17%21%16%
Gross Profit Growth19%19%18%19%
EBITDA Growth21%28%29%45%
EBIT Growth20%33%25%54%
Net Profit Growth16%29%23%31%
FCF Growth34%74%91%64%

Data powered by FactSet, Inc. and Morningstar, Inc.

Intuitive Surgical Operational KPIs

Intuitive Surgical's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.2M for the same period.

Intuitive Surgical's Rule of 40 is 61% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Intuitive Surgical's Rule of X is 85% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Intuitive Surgical
LTMLast FY202320242025202620272028
Rule of 4059%61%
Bessemer Rule of X82%85%
Revenue per Employee$0.6M
Opex per Employee$0.2M
R&D Expenses to Revenue11%13%14%14%13%
Opex to Revenue37%42%39%37%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Intuitive Surgical Competitors

Intuitive Surgical competitors include Abbott, Thermo Fisher Scientific, Stryker, Danaher, Medtronic, Boston Scientific, Siemens, Edwards Lifesciences, Siemens Healthineers and IDEXX Laboratories.

Most Intuitive Surgical public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Abbott4.1x3.9x14.9x14.6x
Thermo Fisher Scientific4.6x4.5x17.7x17.7x
Stryker5.2x5.1x18.3x17.8x
Danaher5.2x5.2x16.7x16.4x
Medtronic3.5x3.3x12.3x11.7x
Boston Scientific4.6x4.5x14.9x14.3x
Siemens2.9x2.8x14.5x15.8x
Edwards Lifesciences7.3x7.0x24.5x23.0x

This data is available for Pro users. Sign up to see all Intuitive Surgical competitors and their valuation data.

Start Free Trial

Intuitive Surgical M&A Activity

Intuitive Surgical has acquired 3 companies to date.

Last acquisition by Intuitive Surgical was on March 1st 2026. Intuitive Surgical acquired ABEX Excelencia Robótica for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Intuitive Surgical

ABEX Excelencia Robótica
Orpheus Medical
Luna Innovations
Description
ABEX Excelencia Robótica manufactures and distributes robotic surgery systems for healthcare.
Orpheus Medical is a developer of video-on-demand systems for operating rooms using digital broadcasting technology. Its platform streams surgical procedures throughout hospitals, integrating with existing OR equipment to facilitate collaboration and process efficiency. The solution targets hospitals seeking cost-effective tools for real-time video sharing and on-demand access to procedures.
Luna Innovations Inc is engaged in optical technology, providing high-performance fiber optic test, measurement, and control products for the telecommunications, and photonics industries, and distributed fiber optic sensing solutions that measure and monitor materials and structures for applications in aerospace, automotive, oil, and gas, security, and infrastructure. Its Lightwave segment develops, manufactures, and markets optical measurements technologies like Sensing including short, medium, and long-range distributed fiber optic sensing solutions and Terahertz measurement products, and Communications test and photonic control including test equipment for communications devices and networks and specialty laser and photonic components. It derives a majority of its revenue from the U.S.
HQ CountrySpainIsraelUnited States
HQ City
Madrid
Haifa
Roanoke, VA
Deal Date1 Mar 202611 Feb 202022 Jan 2014
Valuationundisclosedundisclosed$12M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Intuitive Surgical acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Intuitive Surgical

When was Intuitive Surgical founded?Intuitive Surgical was founded in 1995.
Where is Intuitive Surgical headquartered?Intuitive Surgical is headquartered in United States.
How many employees does Intuitive Surgical have?As of today, Intuitive Surgical has over 17K employees.
Who is the CEO of Intuitive Surgical?Intuitive Surgical's CEO is David J. Rosa.
Is Intuitive Surgical publicly listed?Yes, Intuitive Surgical is a public company listed on Nasdaq.
What is the stock symbol of Intuitive Surgical?Intuitive Surgical trades under ISRG ticker.
When did Intuitive Surgical go public?Intuitive Surgical went public in 2000.
Who are competitors of Intuitive Surgical?Intuitive Surgical main competitors include Abbott, Thermo Fisher Scientific, Stryker, Danaher, Medtronic, Boston Scientific, Siemens, Edwards Lifesciences, Siemens Healthineers, IDEXX Laboratories.
What is the current market cap of Intuitive Surgical?Intuitive Surgical's current market cap is $156B.
What is the current revenue of Intuitive Surgical?Intuitive Surgical's last 12 months revenue is $11B.
What is the current revenue growth of Intuitive Surgical?Intuitive Surgical revenue growth (NTM/LTM) is 15%.
What is the current EV/Revenue multiple of Intuitive Surgical?Current revenue multiple of Intuitive Surgical is 14.2x.
Is Intuitive Surgical profitable?Yes, Intuitive Surgical is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Intuitive Surgical?Intuitive Surgical's last 12 months EBITDA is $5B.
What is Intuitive Surgical's EBITDA margin?Intuitive Surgical's last 12 months EBITDA margin is 44%.
What is the current EV/EBITDA multiple of Intuitive Surgical?Current EBITDA multiple of Intuitive Surgical is 32.2x.
What is the current FCF of Intuitive Surgical?Intuitive Surgical's last 12 months FCF is $3B.
What is Intuitive Surgical's FCF margin?Intuitive Surgical's last 12 months FCF margin is 32%.
What is the current EV/FCF multiple of Intuitive Surgical?Current FCF multiple of Intuitive Surgical is 44.0x.
How many companies Intuitive Surgical has acquired to date?As of May 2026, Intuitive Surgical has acquired 3 companies.
What was the largest acquisition by Intuitive Surgical?$12M acquisition of Luna Innovations on 22nd January 2014 was the largest M&A Intuitive Surgical has done to date.
What companies Intuitive Surgical acquired?Intuitive Surgical acquired Luna Innovations, ABEX Excelencia Robótica, and Orpheus Medical.
In how many companies Intuitive Surgical has invested to date?Intuitive Surgical hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Intuitive Surgical

Lists including Intuitive Surgical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial